Literature DB >> 11229789

Possible neurobiological mechanisms underlying faster onset of antidepressant action.

P Blier1.   

Abstract

All antidepressant drugs have a delayed onset of action. There is, however, evidence that some agents may attenuate depressive symptoms more rapidly than others. The present review examines the mechanisms by which selective serotonin reuptake inhibitors, the dual 5-HT norepinephrine reuptake inhibitor venlafaxine, and the alpha2-adrenoceptor antagonist mirtazapine alter 5-HT and/or norepinephrine neurotransmission. Particular attention is given to the time course with which these effects manifest themselves in relation to the possibility that these 3 types of drugs may act more rapidly, or exert a greater antidepressant action, than other agents. Based on the effects of antidepressant drugs presently available, strategies to accelerate or augment the antidepressant response are described, some of which have already been examined in patients.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11229789

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  11 in total

1.  Single-action versus dual-action antidepressants.

Authors:  Rakesh Jain
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2004

Review 2.  Targeting two-pore domain K(+) channels TREK-1 and TASK-3 for the treatment of depression: a new therapeutic concept.

Authors:  M Borsotto; J Veyssiere; H Moha Ou Maati; C Devader; J Mazella; C Heurteaux
Journal:  Br J Pharmacol       Date:  2014-11-24       Impact factor: 8.739

Review 3.  Trends in the development of new antidepressants. Is there a light at the end of the tunnel?

Authors:  Pal Pacher; Valeria Kecskemeti
Journal:  Curr Med Chem       Date:  2004-04       Impact factor: 4.530

4.  Strategy to Accelerate or Augment the Antidepressant Response and for An Early Onset of SSRI Activity. Adjunctive Amisulpride to Fluvoxamine in Major Depressive Disorder.

Authors:  Maria Carolina Hardoy; Mauro Giovanni Carta
Journal:  Clin Pract Epidemiol Ment Health       Date:  2010-01-27

5.  Spadin, a sortilin-derived peptide, targeting rodent TREK-1 channels: a new concept in the antidepressant drug design.

Authors:  Jean Mazella; Olivier Pétrault; Guillaume Lucas; Emmanuel Deval; Sophie Béraud-Dufour; Carine Gandin; Malika El-Yacoubi; Catherine Widmann; Alice Guyon; Eric Chevet; Said Taouji; Grégory Conductier; Alain Corinus; Thierry Coppola; Gabriella Gobbi; Jean-Louis Nahon; Catherine Heurteaux; Marc Borsotto
Journal:  PLoS Biol       Date:  2010-04-13       Impact factor: 8.029

6.  Selective serotonin reuptake inhibitors potentiate the rapid antidepressant-like effects of serotonin4 receptor agonists in the rat.

Authors:  Guillaume Lucas; Jenny Du; Thomas Romeas; Ouissame Mnie-Filali; Nasser Haddjeri; Graciela Piñeyro; Guy Debonnel
Journal:  PLoS One       Date:  2010-02-16       Impact factor: 3.240

7.  Interaction between estrogens and antidepressants in the forced swimming test in rats.

Authors:  Erika Estrada-Camarena; Alonso Fernández-Guasti; Carolina López-Rubalcava
Journal:  Psychopharmacology (Berl)       Date:  2004-01-17       Impact factor: 4.530

8.  Reboxetine: a preliminary report on its use through the Special Access Program.

Authors:  Sidney H Kennedy; Raymond W Lam; Nicole L Cohen; Michael Rosenbluth; Stephen T H Sokolov; Roger S McIntyre; Pierre Chue; Gerry Craigen
Journal:  J Psychiatry Neurosci       Date:  2002-11       Impact factor: 6.186

Review 9.  Rapid onset of antidepressant action: a new paradigm in the research and treatment of major depressive disorder.

Authors:  Rodrigo Machado-Vieira; Giacomo Salvadore; David A Luckenbaugh; Husseini K Manji; Carlos A Zarate
Journal:  J Clin Psychiatry       Date:  2008-06       Impact factor: 4.384

10.  Aripiprazole augmentation in patients with resistant obsessive compulsive disorder: a pilot study.

Authors:  Roberto Delle Chiaie; Pierluigi Scarciglia; Massimo Pasquini; Maria Caredda; Massimo Biondi
Journal:  Clin Pract Epidemiol Ment Health       Date:  2011-05-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.